0001209191-20-064258.txt : 20201217 0001209191-20-064258.hdr.sgml : 20201217 20201217204407 ACCESSION NUMBER: 0001209191-20-064258 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201211 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bogue Zachary CENTRAL INDEX KEY: 0001836157 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397733 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JNK Capital Management, LLC CENTRAL INDEX KEY: 0001836273 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397734 BUSINESS ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DCVC Bio, L.P. CENTRAL INDEX KEY: 0001735069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397735 BUSINESS ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DCVC Bio GP, LLC CENTRAL INDEX KEY: 0001735070 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397736 BUSINESS ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZNM Capital Management, LLC CENTRAL INDEX KEY: 0001836103 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397737 BUSINESS ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ocko Matthew CENTRAL INDEX KEY: 0001836089 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397738 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stead Kiersten CENTRAL INDEX KEY: 0001836117 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397739 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2020-12-11 2020-12-11 0 0001703057 AbCellera Biologics Inc. ABCL 0001735069 DCVC Bio, L.P. 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001735070 DCVC Bio GP, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836103 ZNM Capital Management, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836089 Ocko Matthew 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836117 Stead Kiersten 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836157 Bogue Zachary 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836273 JNK Capital Management, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 Series A1 Preferred Shares Common Shares 21052640 I See footnote Series A2 Preferred Shares Common Shares 8023710 I See footnote Convertible Note 17.00 Common Shares 29411 I See footnote The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the "Preferred Shares") are convertible into Common Shares at a 1:10 ratio into the number of Common Shares as shown in Column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Preferred Shares have no expiration date. These securities are held by DCVC Bio, L.P. ("DCVC Bio"). DCVC Bio GP, LLC ("DCVC Bio GP") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC ("JNK") and ZNM Capital Management, LLC ("ZNM") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio. (Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any. The convertible promissory note ("Convertible Note") has a maturity date of October 30, 2025 and the principal amount of the Convertible Note will convert upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share. This amendment is being filed to add certain Reporting Persons that were inadvertently not included on the Form 3 initially filed. The holdings reported in this amendment are not new or revised but are being reported to gain access to the SEC's EDGAR filing system. This is one of two Form 3s filed on the date hereof in respect of these securities. The Reporting Person for the other Form 3 is John Hamer. DCVC Bio, L.P. By: DCVC Bio GP, LLC Its: General Partner By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2020-12-17 DCVC Bio GP, LLC By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2020-12-17 ZNM Capital Management, LLC By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2020-12-17 Matthew Ocko /s/ Matthew Ocko 2020-12-17 Kiersten Stead /s/ Kiersten Stead 2020-12-17 Zachary Bogue /s/ Zachary Bogue 2020-12-17 JNK Capital Management, LLC, By: /s/ Kiersten Stead Kiersten Stead, Managing Member 2020-12-17